Characterization of the anaphylatoxin inactivator and chemotactic factor inactivator activities during cardiopulmonary bypass.
Kreutzer, D L
Characterization of the anaphylatoxin inactivator and chemotactic factor inactivator activities during cardiopulmonary bypass. [electronic resource] - Journal of experimental pathology 1984 - 183-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0730-8485
Anaphylatoxins--antagonists & inhibitors
Cardiopulmonary Bypass--adverse effects
Chemotactic Factors--antagonists & inhibitors
Complement C3--metabolism
Complement C3a
Complement C5--metabolism
Complement C5a
Humans
Kinetics
Lung--blood supply
Lysine Carboxypeptidase--metabolism
Peptides--antagonists & inhibitors
Pulmonary Edema--etiology
Respiration Disorders--etiology
Vascular Diseases--etiology
Characterization of the anaphylatoxin inactivator and chemotactic factor inactivator activities during cardiopulmonary bypass. [electronic resource] - Journal of experimental pathology 1984 - 183-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0730-8485
Anaphylatoxins--antagonists & inhibitors
Cardiopulmonary Bypass--adverse effects
Chemotactic Factors--antagonists & inhibitors
Complement C3--metabolism
Complement C3a
Complement C5--metabolism
Complement C5a
Humans
Kinetics
Lung--blood supply
Lysine Carboxypeptidase--metabolism
Peptides--antagonists & inhibitors
Pulmonary Edema--etiology
Respiration Disorders--etiology
Vascular Diseases--etiology